Gyon Technologies Capital Management, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gyon Technologies Capital Management, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$594,000
-68.0%
14,906
-66.1%
0.11%
-81.9%
Q2 2021$1,859,000
+541.0%
43,971
+617.4%
0.61%
+383.3%
Q1 2021$290,000
-60.6%
6,129
-49.2%
0.13%
-50.2%
Q4 2020$736,000
+38.6%
12,057
+6.1%
0.25%
-39.3%
Q3 2020$531,000
-11.9%
11,364
-4.4%
0.42%
-71.4%
Q2 2020$603,000
-9.9%
11,892
-14.6%
1.46%
+229.6%
Q4 2019$669,00013,9250.44%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders